查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049498

內分泌檢測市場報告：按檢測類型、技術、最終用途和地區分類（2026-2034 年）

Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年全球內分泌檢測市場規模達128億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到220億美元，2026年至2034年的複合年成長率為6.02%。

內分泌檢查是指透過醫學手段測量體內荷爾蒙水平並診斷荷爾蒙相關疾病。這些檢查有助於發現可能導致某些慢性疾病的荷爾蒙失衡。此類檢查通常包括細切片檢查（FNA）、超音波、電腦斷層掃描（CT）、磁振造影（MRI）、正子斷層掃描（PET）、放射性碘掃描（RAI）和靜脈血液採樣。檢查結果有助於確定疾病進展並監測患者所接受治療的療效。

腎上腺功能不全、庫欣氏症、巨人症、甲狀腺機能低下症減退症和甲狀腺功能亢進症等內分泌相關疾病的日益普遍是推動市場成長的主要因素之一。此外，人們健康意識的提高以及對及時檢測益處的認知不斷加深，也促進了市場成長。定期檢測能夠最大限度地降低併發症和疾病進展的風險，尤其對老年患者而言。因此，老年人口的成長是推動市場成長的另一個主要因素。此外，新冠肺炎疫情促使內分泌檢測被廣泛用於檢測感染患者的高血糖。而且，創新、易於使用的生物感測器檢測套組的開發，使得用戶能夠在家中進行便利且經濟高效的診斷，這為市場帶來了良好的前景。先進的液相層析法質譜聯用（LC-MS）技術也被醫療機構、檢查室和診斷中心採用，以提供高度精確的檢測結果。其他因素，包括醫療基礎設施的改善，預計也將進一步推動市場發展。

本報告解答的主要問題

  • 全球內分泌檢測市場迄今為止的發展趨勢是什麼？您預計未來幾年該市場將如何發展？
  • 新冠疫情對全球內分泌檢測市場產生了哪些影響？
  • 主要區域市場有哪些？
  • 依檢測類型分類，市場區隔如何？
  • 按技術分類的市場組成是什麼？
  • 依最終用途分類的市場區隔如何？
  • 該產業價值鏈包含哪些不同階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球內分泌檢測市場的結構是怎麼樣的？主要參與者有哪些？
  • 這個行業的競爭有多激烈？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球內分泌檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依測試類型分類

  • 甲狀腺檢查
  • 胰島素測試
  • 人類絨毛膜促性腺激素分泌(HCG) 檢測
  • 催乳素試驗
  • 黃體激素試驗
  • 孕酮測試
  • 其他

第7章 市場區隔：依技術分類

  • 免疫檢測
  • 串聯式質譜質譜法
  • 感測器技術
  • LC-MS
  • 其他

第8章 市場區隔：依最終用途分類

  • 醫院
  • 門診部
  • 臨床實驗室
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioMerieux SA
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG（Roche Holding AG）
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG（Siemens Aktiengesellschaft）
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A2900

The global endocrine testing market size reached USD 12.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 22.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.02% during 2026-2034.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

KEY MARKET SEGMENTATION:

Breakup by Test Type:

  • Thyroid Test
  • Insulin Test
  • Human Chorionic Gonadotropin Test
  • Prolactin Test
  • Luteinizing Hormone Test
  • Progesterone Test
  • Others

Breakup by Technology:

  • Immunoassay
  • Tandem Mass Spectroscopy
  • Sensor Technology
  • LC-MS
  • Others

Breakup by End Use:

  • Hospitals
  • Ambulatory Care Centers
  • Clinical Laboratories
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global endocrine testing market performed so far and how will it perform in the coming years ?
  • What has been the impact of COVID-19 on the global endocrine testing market ?
  • What are the key regional markets ?
  • What is the breakup of the market based on the test type ?
  • What is the breakup of the market based on the technology ?
  • What is the breakup of the market based on the end use ?
  • What are the various stages in the value chain of the industry ?
  • What are the key driving factors and challenges in the industry ?
  • What is the structure of the global endocrine testing market and who are the key players ?
  • What is the degree of competition in the industry ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endocrine Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Thyroid Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Insulin Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Human Chorionic Gonadotropin Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prolactin Test
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Luteinizing Hormone Test
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Progesterone Test
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunoassay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tandem Mass Spectroscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sensor Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 LC-MS
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DiaSorin S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Laboratory Corporation of America Holdings
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2025
  • Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2025
  • Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2025
  • Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
  • Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
  • Figure 90: Global: Endocrine Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Endocrine Testing Market Structure
  • Table 7: Global: Endocrine Testing Market: Key Players